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Objective: Prior studies of gender differences in abdominal aortic aneurysm (AAA) repair suggest there may be differences
in presentation, suitability for endovascular aneurysm repair (EVAR), and outcomes between men and women.
Methods: We used the Vascular Study Group of New England database to identify all patients undergoing EVAR or open
AAA repair. We analyzed demographics, comorbidities, and procedural, and perioperative data. Results were compared
using the Fisher exact test and the Student t-test. Multivariable logistic regression and Cox proportional hazards
modeling were performed to identify predictors of mortality.
Results: We identiﬁed 4026 patients (78% men) who underwent AAA repair (54% EVAR). Women were less likely than
men to undergo EVAR for intact aneurysms (50% vs 60% of intact AAA repair; P < .001) but not for ruptured aneurysms
(26% vs 20%; P [ .23). Women were older (median age, 75 vs 72 years for intact; P < .001; 78 vs 73 years for rupture;
P < .001) with smaller aortic diameters (57 vs 59 mm for elective; P < .001; 71 vs 79 mm for rupture; P < .001). Arterial
injury was more common in women (5.4% vs 2.7%; P [ .013) among patients undergoing EVAR for intact aneurysms.
Women stayed in the hospital longer (4.3 vs 2.7 days; P[ .018) and had lower odds of being discharged home, even after
adjusting for age. Among patients undergoing open repair for intact aneurysms, women more frequently experienced leg
ischemia/emboli (4% vs 1%; P [ .001) and bowel ischemia (5% vs 3%; P [ .044). Women had higher 30-day mortality
after OAR for intact (4% vs 2%; P [ .03) and rupture (48% vs 34%; P [ .03) repairs. However, 30-day mortality after
EVAR was similar for intact (1% in men vs 1% in women; P[ .57) and rupture (29% in men vs 27% in women; P > .99)
repairs. Late survival was worse in women than men only for patients undergoing open repair of ruptured aneurysms
(hazard ratio, 1.8; 95% conﬁdence interval, 1.0-3.1; P [ .04). After controlling for age, type of repair, urgency at
presentation (ie, elective/intact vs ruptured), comorbidities, and other relevant risk factors, gender was not predictive of
30-day or 1-year mortality.
Conclusions: Women with AAAs are being treated at older ages and smaller AAA diameters and are undergoing rupture
repair at smaller diameters than men. Women are more likely to experience perioperative complications as a result of less
favorable vascular anatomy. Age >80 years, comorbidity, presentation, and type of repair are more important predictors
of mortality than gender. (J Vasc Surg 2013;57:1261-8.)Although abdominal aortic aneurysm (AAA) is a disease
primarily of men, with a 4:1 male-to-female predomi-
nance,1 women who develop AAAs tend to fare worse
than men. Women with AAAs are older, have faster-
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undergoing repair, women are less likely to undergo the
less morbid endovascular approach (endovascular aneu-
rysm repair [EVAR]).6 Even when EVAR is undertaken
in women, it has been suggested that the survival gain
over open repair by women is inferior to gains observed
in men.7 Regardless of the urgency of presentation or
type of repair, studies frequently show that women have
worse morbidity and short-term and long-term mortality,
even after adjustment for age and comorbidities.8-11
Theories about the etiology of these disparities abound.
Differences in hormonal milieu result in delayed presenta-
tion in women and different degrees of atherosclerosis
and matrix metalloproteinase production.12 The vascular
anatomy of women may limit their eligibility for EVAR
and leave them more prone to vessel injury and procedural
complications.13 Further, because women are generally
smaller in body size, some have argued that an aneurysm
of a certain diameter in a woman represents more advanced
disease than the same-sized aneurysm in a man.14,15 Lastly,
it is documented that women have a higher rate of undiag-
nosed cardiovascular disease16 and are undertreated even1261
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risk of perioperative cardiovascular events.17
There is still no formal consensus about whether men
and women with AAAs should be managed differently.
Our objective was therefore to describe differences in the
presentation, choice of repair, and mortality among men
andwomenundergoingAAA repair. Although the outcomes
we studied are not unique, the strength of this study lies in
the database, which is not only large but also comprehensive
of both academic and community hospitals, contains detailed
clinical information not found in administrative databases,
and has a representative proportion of women.
METHODS
This study was approved by the Institutional Review
Board at Beth Israel Deaconess Medical Center.
Study design. We performed a retrospective review
of open and endovascular AAA repairs in the Vascular Study
Group of New England (VSGNE) database, a voluntary
collaboration among vascular surgeons, cardiologists, and
radiologists from 30 academic and community hospitals
in the six New England states. Formed as a quality-
improvement initiative, VSGNE represents a pool of clinical
data related to several frequently performed vascular proce-
dures that have been collected since 2003. In addition to
detailed perioperative and procedural information, longitu-
dinal outcomes are available at 1 year. Further details about
this registry are available at http://www.vsgne.org. At the
time of this analysis, 1867 open and 2159 endovascular re-
pairs were recorded in the VSGNE between 2003 and 2011.
Patient presentation was categorized as intact (inclu-
ding patients who were symptomatic as well as those
undergoing elective repair) or ruptured. Four subgroup
analyses were performed: intact EVAR, ruptured EVAR,
intact open repair, and ruptured open repair. For the
purposes of multivariable modeling, intact EVAR served
as the referent group.
Postoperative complications. We compared nine
postoperative complications between men and women:
Acute myocardial infarction (MI) was documented if any
of the following were present: isolated troponin elevation,
electrocardiogram change, or clinical evidence of myocar-
dial infarction. Postoperative dysrhythmias were deﬁned
as new rhythm disturbances that required treatment with
medications or cardioversion. Postoperative congestive
heart failure (CHF) was deﬁned as pulmonary edema
with requirement for monitoring or treatment in an inten-
sive care unit (ICU) or step-down unit.
Respiratory complications consisted of pneumonia
(lobar inﬁltrate on chest radiography and pure growth of
recognized pathogen or 4þ growth of a recognized path-
ogen in the presence of mixed growth) or ventilator
requirement after initial extubation. Change in renal func-
tion was deﬁned as a creatinine rise >.5 mg/dL or the
institution of dialysis (peritoneal dialysis, hemodialysis, or
hemoﬁltration), whether temporary or permanent.
Leg ischemia/emboli was deﬁned as the loss of previ-
ously palpable pulses, loss of previously present Dopplersignals, decrease of >0.15 in the ankle-brachial index,
blue toe, or tissue loss. Criteria for diagnosing bowel
ischemia included colonoscopic evidence of ischemia,
bloody stools in a patient who died before colonoscopy
or laparotomy could be performed, or a presumptive diag-
nosis with conservative treatment.
Wound complications ranged from a superﬁcial separa-
tion of the incision to problems requiring return to the
operating room. Any complication that required a trip to
the operating room was tabulated. Bleeding complications
included minor hematomas, those that required fresh
frozen plasma or hemostatic agents to be administered,
and those that required reoperation or other invasive inter-
vention to control.
Statistical analysis. Comparisons between men and
women were made using the Pearson c2 and Fisher exact
test for categoric variables and the Student t-test or Wil-
coxon rank-sum test for continuous variables. Multivariable
logistic regression was used to determine predictors of 30-
day mortality. Individual survival curves for each presenta-
tion and treatment group were evaluated for differences in
survival between men and women. Cox proportional
hazards modeling was used to determine predictors of long-
term mortality. Survival was measured by postoperative
number of days until death or most recent follow-up. For
regression modeling, presentation and treatment subgroup
were categorized into a single variable using intact EVAR as
the referent group. Statistical signiﬁcance was deﬁned as
a value of P< .05. Analyses were performed using Stata 12.0
software (StataCorp, College Station, Tex).
RESULTS
We identiﬁed 4026 patients (78% men) who under-
went AAA repair (Table I). Rupture was the presenting
indication for repair in 11% of men and 9% of women.
Women undergoing intact repair were 3 years older than
men (median age, 75 vs 72 years; P< .001), whereas those
undergoing rupture repair were 5 years older (median age,
78 vs 73 years; P< .001). As a proportion of all repairs, use
of EVAR increased from 40% in 2003 to 73% in 2011.
Men were more likely to undergo EVAR than open repair
for intact repairs (60% EVAR for men vs 50% EVAR for
women; P < .001) but not ruptured repairs (20% EVAR
for men vs 26% EVAR for women; P ¼ .234). Women
had smaller aortic diameters than men for intact (57 vs
59; P < .001) and ruptured (71 vs 78 mm; P < .001)
aneurysms.
From 2003 to 2011, the mean diameter of intact aneu-
rysms being repaired decreased from 60.5 to 57.3 mm for
men (P < .010) and 58.0 to 57.1 mm for women
(P ¼ .118). The proportion of patients undergoing repair
of intact small (<5.5 cm) aneurysms increased from 33% in
2003 to 44% in 2011 for men and from 33% to 47% in
women. These individuals were younger and had lower rates
of congestive heart failure (CHF) and chronic obstructive
pulmonary disease (COPD; Table II). Of all the intact
<5.5-cm aneurysms repaired in both men and women,
only 5% were symptomatic. Perioperative and 1-year
Table I. Presentation of men and women with
abdominal aortic aneurysms (AAAs) and the types of
repair
Variables a Men Women P
Total patients 3122 (78) 904 (22)
Presentation
Intact 89 91 .142
Ruptured 11 9
Age, years
Intact 72 (66, 78) 75 (69, 79) <.001
Ruptured 73 (67, 79) 78 (71, 83) <.001
EVAR
Intact 60 50 <.001
Ruptured 20 26 .234
Max AAA AP
diameter, mm
Intact 59 6 12 57 6 11 <.001
Ruptured 79 6 19 71 6 20 <.001
AP, Anteroposterior; EVAR, endovascular aortic aneurysm repair; IQR,
interquartile range.
aCategoric data are presented as number (percentages) or percentage, and
continuous data are shown as median (IQR) or mean6 standard deviation.
JOURNAL OF VASCULAR SURGERY
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of smaller aneurysms. EVARconstituted a higher proportion
of repairs for small aneurysms for both men and women
(Supplementary Figs 1 and 2, online only).
Demographics and comorbidities
EVAR. Compared with men, women undergoing
EVAR were less likely to have a smoking history, coronary
artery disease (CAD), history of coronary artery bypass
grafting (CABG) or percutaneous coronary intervention
(PCI), but were more likely to have COPD (Table III).
The proportion of patients with a history of hypertension
was similar. Women were less likely to be taking aspirin or
a statin preoperatively.
Open repair. Paralleling trends observed for patients
undergoing EVAR, women undergoing open repair were
also less likely to have a smoking history, CAD, and history
of CABG/PCI than men. Like women undergoing
EVAR, men also had higher rates of COPD and were less
likely to be taking aspirin preoperatively. However, rates of
statin use were similar betweenmen andwomen undergoing
open repair.
Operative details and perioperative outcomes
Intact EVAR. There were 2068 patients (80% men)
who underwent EVAR for intact aneurysms.Women under-
went repair of intact aneurysms at smaller aortic diameters
thanmen (56 vs 58mm; P¼ .004). For patients undergoing
EVAR for intact aneurysms, endografts used more
commonly in men were the AneuRx (Medtronic, Minnea-
polis, Minn) in 16.6% vs 12.6%, Talent (Medtronic) in
8.3% vs 7.5%, Zenith (Cook, Bloomington, Ind) in 26.4%
vs 20.3%, Powerlink (Endologix, Irvine, Calif) in 7.4% vs
6.8%, and Endurant (Medtronic) in 3.9% vs 3.3%. Endog-
rafts used more frequently in women were the Excluder
(W. L. Gore and Assoc, Flagstaff, Ariz) in 42.4% vs 32.4%,Cordis (Cordis, Miami Lakes, Fla) in 0.2% vs 0.1%, Zenith
Low Proﬁle (Cook) in 0.7% vs 0.2%, and the Aptus (Aptus
Endosystems, Sunnyvale, Calif) in 5.8% vs 4.2%. The P value
for the t-test comparing endograft type was 0.008.
Womenweremore likely to have unintentional coverage
of the hypogastric arteries (one: 3.4% vs 1.8%, both: 1.0% vs
0.2%; P ¼ .013), but rates of intentional coverage did not
differ. Rates of unplanned graft extensions and presence of
endoleak at the end of the procedure did not signiﬁcantly
differ between men and women, but arterial injury was
more common in women (5.4% vs 2.7%; P ¼ .013). Proce-
dural times were longer in women (175 vs 163 minutes;
P ¼ .006), but there were no differences in the amount of
contrast used, the estimated blood loss (EBL), or the intra-
operative units of blood transfused.
Postoperatively, vasopressors were administered more
often in women (7.4% vs 3.5%; P ¼ .001), as was transfu-
sion of packed red blood cells (RBCs; 0.4 vs 0.1 units;
P < .001). Women required return to the operating room
more frequently (3.4% vs 1.6%; P ¼ .025), stayed in the
hospital longer (4.3 vs 2.7 days; P ¼ .018), and were more
often discharged somewhere other than home (14.1% vs
6.2%;P< .001).Womenhad lower odds of being discharged
home, even after adjusting for age (hazard ratio [HR],
0.5; 95% CI, 0.3-0.7; P < .001). Details of intact EVAR
are available in Supplementary Table I (online only).
Ruptured EVAR. Ninety-one patients (76% men)
underwent EVAR for rupture. Women with ruptured aneu-
rysms undergoing EVAR had smaller aneurysms than men,
but this difference was not statistically signiﬁcant (73 vs
76 mm; P ¼ .510). There were no differences in type of
endografts used, presence of endoleak, rates of arterial
injury, amounts of contrast used, EBL, units of RBCs trans-
fused, or total procedural time. Postoperatively, women
stayed in the ICU longer than men (8.0 vs 3.4 days;
P¼ .015) but did not differ in the rate of vasopressor admin-
istration or postoperative blood transfusion. Wound
complications were more common in women (19.1% vs
1.6%; P ¼ .013). However, only 69 men and 22 women
underwent rupture EVAR such that the absolute difference
was only three wound complications (one among men and
four among women), suggesting this comparison may
have been signiﬁcant by chance, particularly because there
was no difference in wound complications among men
and women undergoing EVAR for intact aneurysms. There
were no other signiﬁcant differences in the rate of other post-
operative complications, but women nonetheless remained
in the hospital longer (15.3 vs 6.8 days; P ¼ .009). Details
for ruptured EVAR are presented in Supplementary Table II
(available online).
Intact open repair. Open repair for an intact aneurysm
was performed in 1529 patients (73% men). Women under-
went open repair of intact aneurysms at smaller diameters
than men (58 vs 62 mm; P < .001). The proportion of
repairs representing conversion from EVAR was higher in
women, but this difference was not statistically signiﬁcant
(1.7% vs 0.5%; P ¼ .052). Rates of retroperitoneal exposure
also were not different between genders.Womenweremore
Table II. Demographics and mortality of patients undergoing repair of intact small (<5.5 cm) vs large ($5.5 cm)
aneurysms
Variablea
Men Women
<5.5 cm $5.5 cm P <5.5 cm $5.5 cm P
Total patients 986 (36) 1791 (64) 350 (43) 470 (57)
Age, years 70 6 8 73 6 8 <.001 72 6 8 75 6 8 <.001
EVAR 65 57 <.001 56 45 .003
Symptoms 4 8 <.001 7 11 .025
Smoking history 89 90 .725 88 83 .038
Hypertension 82 84 .093 82 88 .015
Diabetes mellitus 18 18 .856 15 16 .902
Coronary artery disease 34 37 .155 25 27 .657
Congestive heart failure 6 11 <.001 7 11 .063
CABG/PCI 33 33 .875 19 18 .838
COPD 30 35 .010 42 43 .688
Dialysis 0.9 0.8 .715 0.0 0.9 .084
Thirty-day survival 0.7 1.5 .067 1.1 3.4 .038
One-year survival 4 7 .007 3 8 .003
CABG, Coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; EVAR, endovascular aneurysm repair; PCI, percutaneous coronary
intervention.
aContinuous data are shown as median 6 standard deviation and categoric data as number (percentage) or as percentage.
Table III. Baseline demographics, comorbidities, and preoperative medication use of men and women undergoing
endovascular (EVAR) and open repair of abdominal aortic aneurysms (AAAs)
Variablea
EVAR Open aneurysm repair
Male Female
P
Male Female
P(n ¼ 1729) (n ¼ 430) (n ¼ 1393) (n ¼ 474)
Age, years 74 (67, 80) 77 (71, 81) <.001 71 (64, 77) 73 (68, 78) <.001
White 98 98 .851 98 98 >.99
Comorbidities
Smoking history 87 80 <.001 92 88 .011
Hypertension 85 84 .881 81 86 .008
Diabetes mellitus 20 19 .634 15 13 .361
Coronary artery disease 37 27 <.001 35 27 .001
Congestive heart failure 11 12 .442 7.4 6.8 .757
CABG/PCI 33 18 <.001 31 19 <.001
COPD 34 41 .010 33 45 <.001
Dialysis 1.0 0.5 .398 0.6 0.4 >.99
Preoperative medications
Aspirin 71 65 .011 69 63 .040
Clopidogrel 7 6 .386 5.0 6.2 .341
Statin 69 61 .001 61 58 .327
b-blocker 76 75 .704 80 79 .508
Family history of AAA 13 13 .619 15 16 .392
Prior aortic surgery 2.7 2.6 >.99 3.4 4.3 .392
Nursing home resident 1.0 1.4 .434 0.5 1.7 .031
CABG, Coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention.
aContinuous data are shown as median (interquartile range) and categoric data as percentage.
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bifurcated repairs, women were more likely to have femoral
vs iliac anastomoses (femoral: 18.5% vs 14.3%, common
iliac: 3.7% vs 7.9%, external iliac: 18.7% vs 27.6%;
P < .001). Women were less likely to have an infrarenal
proximal clamp position (65% vs 74%; P ¼ .010). Women
had lower EBL (1261 vs 1563 mL; P< .001) and less auto-
transfusion (568 vs 788 mL; P < .001) but greater intrao-
perative transfusion of RBCs (0.9 vs 0.6 units; P ¼ .001).Women were in the ICU longer (5.2 vs 3.5 days;
P ¼ .001) and more frequently developed complications of
dysrhythmia (17% vs 12%; P ¼ .024), CHF (7% vs 4%;
P ¼ .056), leg ischemia/emboli (4% vs 1%; P ¼ .001), and
bowel ischemia (5.0% vs 3%; P ¼ .044). Not surprisingly,
on average, they stayed in the hospital more than a day
longer than men (10.8 vs 9.3 days; P ¼ .050) and more
frequently were not discharged home (28.5% vs 17.4%;
P < .001). Again, women had lower odds of being
Fig 1. Gender differences in in-hospital, 30-day, and 1-year mortality following endovascular (EVAR) and open repair
of intact and ruptured abdominal aortic aneurysms (AAAs).
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CI, 0.5-0.8; P ¼ .001). Details on intact open repair are
available in Supplementary Table III (online only).
Ruptured open repair. There were 338 patients (82%
men) who underwent open repair for a ruptured aneurysm.
Aneurysm diameter was smaller in women (71.0 vs
79.3 mm; P < .001). As with intact open repairs, the distal
anastomosis was more frequently to the aorta and common
femoral artery in women and to the common and external
iliac arteries in men. However, this difference was not signif-
icant for open repair of ruptured AAAs. Other than a lower
rate of autotransfusion (3336 vs 3997 mL; P ¼ .013),
women did not differ from men in renal visceral ischemia
time, EBL, intraoperative or postoperative blood transfu-
sion, or procedural time. Postoperative vasopressor require-
ment and ICU stay also did not differ signiﬁcantly between
men and women. Women had higher rates of dysrhythmia
(33% vs 20%; P ¼ .045) and tended to have more leg
ischemia/emboli complications (15% vs 7%; P ¼ .055).
However, rates of other complications were comparable. A
similar proportion of men and women were not discharged
home (52 vs 67%; P ¼ .169). Further details are available in
Supplementary Table IV (online only).
Mortality. In-hospital deaths were the majority of
deaths that occurred within the ﬁrst 30 days (Fig 1).
Crude in-hospital, 30-day, and 1-year mortality were similar
betweenmen andwomen undergoing EVAR for both intact
and ruptured aneurysms. In contrast, 30-day mortality
was higher in women undergoing open repair for intactaneurysms than in men (3.6% vs 1.7%; P ¼ .030). Women
also had higher in-hospital (51.6% vs 34.4%; P ¼ .014),
30-day (48.4% vs 34.1%; P ¼ .041), and 1-year mortality
(58.0% vs 40.9%; P ¼ .016) after open repair for ruptured
aneurysms. Crude in-hospital mortality was lower after
EVAR than after open repair for intact (0.5% for EVAR vs
2.2% for open; P< .001) but not ruptured (34.4% for EVAR
vs 24.6% for open; P ¼ .150) aneurysms.
No survival beneﬁt was seen in men undergoing EVAR
over men undergoing open repair at 30 days and 1 year.
For women, crude in-hospital and 30-day mortality were
lower for EVAR than open repair for intact (in-hospital:
1.0% for EVAR vs 3.4% for open; P ¼ .029; 30-day: 1.2%
for EVAR vs 3.6% for open; P¼ .039), but these differences
didnot attain statistical signiﬁcance for ruptured (in-hospital:
27.3% for EVAR vs 51.6% for open; P ¼ .080; 30-day:
27.3% for EVAR vs 48.4% for open; P ¼ .132) aneurysms.
A sample size calculation assuming an a ¼ 0.05 and
90% power indicated a minimum of 87 women would be
needed in each group to detect a 25% mortality difference
(among the women in our cohort, 22 underwent EVAR
and 62 underwent open repair for rupture). In addition,
there were no differences in 1-year mortality between
women undergoing EVAR vs women undergoing open
repair for intact or ruptured repairs.
Multivariable predictors of 30-day mortality were age,
CAD, preoperative dialysis dependence, and presenta-
tion/treatment subgroup (intact vs ruptured and EVAR
vs open repair; Table IV). Age >80 years increased the
Table IV. Multivariable predictors of 30-day and long-
term mortality
Variable OR (95% CI) P
Thirty-day mortality
Age, years
<60 Reference
60-69 1.9 (1.0-3.5) .042
70-79 3.1 (1.6-6.0) .001
$80 10.9 (3.3-36.5) <.001
Female 1.7 (1.0-2.8) .063
Coronary artery disease 1.7 (1.0-2.8) .043
Dialysis 9.5 (1.1-85.7) .044
Treatment subgroup
Intact EVAR Reference
Intact OAR 3.3 (1.2-9.0) .024
Ruptured EVAR 48.4 (14.8-157.9) <.001
Ruptured OAR 83.8 (30.8-227.7) <.001
Long-term mortality
Age, years
<60s Reference
60-69 1.6 (1.2-2.0) .001
70-79 2.7 (2.0-3.5) <.001
$80 4.8 (2.6-8.7) <.001
Gender 1.1 (0.9-1.4) .445
Coronary artery disease 1.4 (1.1-1.7) .004
Congestive heart failure 1.4 (1.0-1.8) .025
COPD 1.5 (1.2-1.8) <.001
Treatment subgroup
Intact EVAR Reference
Intact OAR 1.3 (0.9-1.6) .112
Ruptured EVAR 4.3 (2.6-7.3) <.001
Ruptured OAR 2.7 (1.9-3.8) <.001
CI, Conﬁdence interval; COPD, chronic obstructive pulmonary disease;
EVAR, endovascular aneurysm repair; OAR, open aneurysm repair; OR,
odds ratio.
Fig 2. Survival of patients undergoing open repair of ruptured
aneurysms.
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odds by 48.4 for EVAR and 83.8 for open repair. Female
gender did not reach statistical signiﬁcance as a predictor
of 30-day mortality.
Using Kaplan-Meier survival analysis, we observed
similar survival between men and women undergoing intact
repairs out to 3 years for EVAR and open repair. For patients
with ruptured aneurysms undergoing EVAR, survival at 1
year was 54% in women and 67% in men (HR, 1.1; 95%
CI, 0.5-2.4; P ¼ .741). One-year survival among patients
with ruptured aneurysms undergoing open repair was 50%
in women vs 68% in men (HR, 1.6; 95% CI, 1.0-2.4;
P ¼ .033; Fig 2). The highest mortality for all patients with
rupture occurred within the ﬁrst year, and it was also during
this time that the greatest gender disparity in mortality
became apparent. Long-term mortality was predicted by
age, comorbidities (CAD, CHF, and COPD), and presenta-
tion/treatment subgroup. Of note, patients undergoing
EVAR for rupture had higher odds of long-term mortality
than those undergoing open repair for rupture. Gender
was not predictive of long-term mortality.
DISCUSSION
In this study, we sought to characterize gender dispar-
ities in presentation, treatment, and outcomes after AAArepair using a largemulticenter database inclusive of commu-
nity and academic hospitals that contained a representative
sample of women. Women presented at an older age and
ruptured at smaller aortic diameters than men, but the
proportion of ruptured repairs was not higher in women.
When undergoing elective repair, women were repaired at
smaller diameters.
From 2003 to 2011, the size of aneurysms at elective
repair has decreased for both genders but to a greater
degree for men than for women. This could be partly
due to an increase in aneurysm detection through
screening, but because we do not have data about ruptures
treated nonoperatively, we cannot speculate whether this
trend has lowered the proportion of patients who present
with rupture. Despite evidence from randomized
controlled trials suggesting no survival beneﬁt to repairing
small (4.0-5.5 cm) aneurysms regardless of repair type,18
35% of men and 43% of women with intact aneurysms in
our study underwent repair at diameters <5.5 cm and ulti-
mately experienced lower perioperative and long-term
mortality. The decision to pursue elective AAA repair is
dependent on factors besides just aneurysm size, such as
patient surgical risk, life expectancy, and personal prefer-
ence. These variables were not precisely captured in the
VSGNE database. However, we did note that patients
undergoing repair of small aneurysms were younger, gener-
ally had fewer comorbidities, and were less likely to
undergo open repair. The lower perioperative and 1-year
mortality observed in the group with small aneurysms
suggests that surgeons may be selecting patients according
to Society for Vascular Surgery guidelines, which state that
repair at smaller sizes (4.5-5.5 cm) may be indicated in
younger low-risk patients who prefer early repair.19
Women were less likely to undergo EVAR for intact
aneurysms. The most likely reason for this is that women
less frequently meet the anatomic criteria for EVAR. This
has been observed in several studies,20,21 including one
by Sweet et al,13 who showed that even after adjustment
for age and aneurysm size, women have decreased neck
JOURNAL OF VASCULAR SURGERY
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Indeed, women undergoing EVAR in the VSGNE had
signiﬁcantly smaller graft limb diameters (right limb:
14.3 vs 15.7 mm; P < .001; left limb: 14.2 vs 15.9 mm;
P < .001). In the study by Sweet et al,13 these features
resulted in a lower likelihood of women meeting device
instructions for use criteria. Although we did not have iliac
artery size measurements, we did observe that lower-proﬁle
endografts, such as the Excluder, Cordis, and Zenith Low
Proﬁle, were more frequently used in women.
When women did undergo EVAR, they experienced
higher rates of intraoperative complications, including arte-
rial injury and unplanned graft extension. We suspect that
this is again related to less favorable iliac anatomy making
graft placement more difﬁcult or complicated by injury
and necessitating extension and coverage. Women under-
going EVAR also experienced greater morbidity postoper-
atively, as evidenced by longer ICU stays and higher rates
of bowel ischemia and complications requiring a return to
the operating room. Abedi et al9 described gender dispar-
ities among patients undergoing EVAR using the American
College of Surgeons-National Surgical Quality Improve-
ment Program data set. Although preoperative, intraoper-
ative, and complication data captured in the National
Surgical Quality Improvement Program at the time were
not speciﬁc to AAA patients, they also observed more post-
operative complications in women, reporting women had
1.7 higher odds of operative morbidity than men.
Gender disparities in perioperative outcomes were also
evident in patients who underwent open repair of intact
aneurysms. Our study is one of very few to offer a compar-
ison of intraoperative and procedural details and vascular
complications speciﬁc to AAA repair between men and
women. The primary outcome reported in most prior
studies has beenmortality. Of the few that did report speciﬁc
postoperative complications, most did not ﬁnd signiﬁcant
differences between men and women, possibly due to
smaller cohort sizes. In their study of 675 patients from
1983 to 2003, Bonamigo et al22 found no differences in
duration of surgery or EBL. The men and women in their
study did not differ signiﬁcantly in the postoperative rates
of coronary, pulmonary, renal, gastrointestinal complica-
tions, infectious, or vascular complications, although there
was a trend toward higher rates in women for the latter
two. Johnston23 similarly found no gender differences in
early or late vascular complications in a study of 679 pat-
ients undergoing intact open AAA repair. Our analysis ide-
ntiﬁed longer ICU stays and higher rates of dysrhythmia,
CHF, and embolic and bowel complications in women.
Results of our mortality analyses were surprising.
Despite higher intraoperative and postoperative complica-
tions, there were no differences in 30-day and 1-year
mortality between men and women undergoing EVAR,
regardless of urgency of presentation. Only in a small
subgroup of patients undergoing open repair of ruptured
aneurysms did we see a signiﬁcant mortality difference
between men and women. Thus, our ﬁndings are consis-
tent with an earlier VSGNE report on mortality afterelective AAA repair, in which gender was not found to
be a signiﬁcant predictor of mortality.24 One consistent
multivariable predictor of both 30-day and long-term
mortality was advanced age, particularly age $80 years,
suggesting greater weight should be given to projected
life expectancy when balancing the risks and beneﬁts of
AAA repair.
Mehta et al,7 who recently published the results of their
single-institution 7-year experience with 2631 open and
endovascular AAA repairs, found no differences in 30-day
mortality among men and women undergoing elective
open, ruptured open, or ruptured endovascular repair.
However, among their patients undergoing elective
EVAR, the odds of 30-day mortality were 3.4 times higher
in women after adjustment for age, aneurysm size, and
other risk factors. It is unclear why disparities were only
seen among their patients undergoing elective EVAR
(a ﬁnding not previously reported in other gender-based
studies) and why these were not seen in our data. The
cohort undergoing elective EVAR in their study was
comparable to ours in sample size, gender-speciﬁc mean
aneurysm sizes, and comorbidities. However, as the
authors acknowledged, their study was based on the expe-
rience of a small group of surgeons from a single institu-
tion, and given that they serve as a referral center, was
likely affected by selection bias.
Population-based studies have reported worse mortality
in women after AAA repair.2,8,9-11 Certainly, these studies
had considerably larger study populations than our current
study or that of Mehta et al.7 Perhaps we would have seen
signiﬁcant gender-associated differences in mortality if our
study population had been larger. We did observe a trend
toward higher 30-day mortality rates among women. The
magnitude and direction of the HR were not quite statisti-
cally signiﬁcant but mirror those reported in population-
based studies, suggesting a possible type II error due to
limitations in population size.
Although our study is retrospective, all data in the
VSGNE are collected prospectively, and this current study
represents the largest study using detailed clinical informa-
tion derived from a broad population, enhancing its gener-
alizability. Another potential limitation was selection bias.
The decision to pursue repair and the method of repair
to perform can depend on a myriad of factors, and differen-
tial selection for repair based on gender may have led to
confounding by unmeasured covariates.CONCLUSIONS
Compared with men, women are older and have
smaller aneurysms when undergoing AAA repair for intact
or ruptured aneurysms. Women who undergo aneurysm
repair are less likely than men to undergo EVAR and
have higher rates of procedural complications. Differences
in operative and late mortality are driven primarily by
rupture, open repair vs EVAR, age, and comorbidity rather
than gender. In fact, gender is not predictive of 30-day and
1-year mortality for intact or ruptured aneurysms.
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Supplementary Fig 1 (online only). Distribution of the size of intact abdominal aortic aneurysms (AAAs) among
men undergoing endovascular aneurysm repair (EVAR) and open repair (OPEN).
Supplementary Fig 2 (online only). Distribution of the size of intact abdominal aortic aneurysms (AAAs) among
women undergoing endovascular aneurysm repair (EVAR) and open repair (OPEN).
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Supplementary Table I (online only). Procedural and postoperative details of patients undergoing endovascular
aneurysm repair (EVAR) for intact aneurysms
Variablea Men Women P
Total patients 1660 (80) 408 (20)
Aneurysm diameter, mm 57.7 6 11.0 55.9 6 9.6 .004
Hypogastric artery
Intentionally covered
None 88.1 90.4 .245
Unilateral 10.5 7.8
Bilateral 1.5 1.7
Unintentionally covered
None 98.0 95.6 .013
Unilateral 1.8 3.4
Bilateral 0.2 1.0
Unplanned graft extension 8.9 11.0 .229
Endoleak at completion
None 74.0 72.1 .824
Type I 2.0 2.7
Type II 22.2 23.5
Type III 0.4 0.3
Type IV 1.3 1.5
Type I or III endoleak 2.4 2.9 .596
Any endoleak at completion 26.0 27.9 .415
Arterial injury 2.7 5.4 .013
Iodinated contrast, mL 118.3 6 70.0 121.6 6 79.3 .421
Estimated blood loss, mL 284.2 6 359.6 297.7 6 343.3 .492
Transfused packed RBCs, units
Intra-op 0.2 6 2.5 0.3 6 1.0 .339
Post-op 0.1 6 0.9 0.4 6 1.2 <.001
Total procedural time, minutes 163.2 6 75.2 174.7 6 80.1 .006
Vasopressors required post-op 3.5 7.4 .001
Post-op complications
Myocardial infarction 2.1 2.2 .847
Dysrhythmia 3.1 2.7 .871
Change in renal function 3.4 3.7 .762
Leg ischemia/emboli 1.0 2.2 .071
Bowel ischemia 0.4 1.2 .069
Wound complication 1.0 1.2 .587
Return to operating room 1.6 3.4 .025
Bleeding 1.9 6.1 .085
Stroke 0.5 0.9 .508
Length of stay, days
Intensive care unit 0.3 6 1.9 0.6 6 2.5 .007
Hospital 2.7 6 10.0 4.3 6 10.4 .018
Not discharged home 6.2 14.1 <.001
RBCs, Red blood cells.
aCategoric data are shown as number (%) or percentage and continuous data as mean 6 standard deviation.
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Supplementary Table II (online only). Procedural and postoperative details of patients undergoing endovascular
aneurysm repair (EVAR) for ruptured aneurysms
Variablea Men Women P
Patient total 69 (76) 22 (24)
Aneurysm diameter, mm 76.2 6 17.8 72.8 6 24.6 .510
Hypogastric artery
Intentionally covered
None 87.9 95.2 .752
Unilateral 10.6 4.8
Bilateral 1.5 0.0
Unintentionally covered
None 98.5 100.0 >.99
Unilateral 1.5 0.0
Bilateral 0.0 0.0
Unplanned graft extension 8.1 25 .058
Endoleak at completion
None 80.3 76.2 .496
Type I 0 4.8
Type II 15.2 19.1
Type III 3.0 0.0
Type IV 1.5 0.0
Type I or III 3.0 4.8 .568
Any endoleak completion 19.7 23.8 .759
Arterial injury 0.0 5.0 .244
Iodinated contrast, mL 136.1 6 92.6 110.6 6 67.5 .258
Estimated blood loss, mL 935.9 6 2643.2 331.4 6 512.9 .302
Packed RBC transfusion, units
Intra-op 3.0 6 3.9 3.5 6 3.3 .615
Post-op 4.3 6 6.2 5.1 6 5.8 .670
Total procedural time, minutes 181.7 6 83.8 172.3 6 73.1 .653
Vasopressors required post-op 38.1 52.4 .310
Post-op complications
Myocardial infarction 11.1 19.1 .455
Dysrhythmia 9.5 19.1 .259
Change in renal function 22.2 20.0 >.99
Leg ischemia/emboli 3.2 0.0 >.99
Bowel ischemia 4.8 9.5 .595
Wound complication 1.6 19.1 .013
Return to operating room 17.2 33.3 .132
Bleeding 21.4 28.6 >.99
Stroke 0.0 0.0 .
Length of stay, days
Intensive care unit, days 3.4 6 5.4 8.0 6 11.4 .015
Hospital 6.8 6 8.0 15.3 6 22.4 .009
Not discharged home 38.5 62.5 .149
RBCs, Red blood cell.
aCategoric data are shown as number (%) or percentage and continuous data as mean 6 standard deviation.
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Supplementary Table III (online only). Procedural and postoperative details of patients undergoing open repair for
intact aneurysms
Variablea Men Women P
Total patients 1117 (73) 412 (27)
Aneurysm diameter 61.5 6 13.9 58.3 6 12.1 <.001
Conversion from EVAR 0.5 1.7 .052
Retroperitoneal exposure 20.2 23.5 .158
Distal anastomosis
Aorta 50.3 59.1 <.001
Common iliac 27.6 18.7
External iliac 7.9 3.7
Common femoral 14.3 18.5
Proximal clamp position
Infrarenal 73.6 64.8 .007
Above one renal artery 8.9 13.5
Above both renal arteries 11.2 14.2
Supraceliac 6.4 7.9
Renal visceral ischemia time, minutes 7.9 6 17.0 9.9 6 19.4 .05
Estimated blood loss, mL 1563.4 6 1408.4 1260.5 6 1020.8 <.001
Autotransfusion, mL 788.3 6 831.9 568.3 6 461.7 <.001
Transfused packed RBCs, units
Intra-op 0.6 6 1.4 0.9 6 1.5 .001
Post-op 0.5 6 1.9 0.7 6 2.0 .130
Total procedural time, minutes 215.1 6 84.7 209.2 6 92.2 .243
Vasopressors required post-op 31.6 34.1 .387
Postoperative complications
Myocardial infarction 6.1 7.1 .480
Dysrhythmia 12.3 17.0 .024
Congestive heart failure 4.0 6.6 .056
Respiratory 11.8 14.1 .222
Change in renal function 12.6 11.3 .536
Leg ischemia/emboli 1.0 3.9 .001
Bowel ischemia 2.5 4.6 .044
Wound complication 4.3 2.9 .238
Return to operating room 6.6 7.3 .646
Bleeding 11.5 8.8 .641
Stroke 1.4 0.0 >.99
Length of stay, days
Intensive care unit 3.5 6 6.0 5.2 6 14.5 .001
Hospital 9.3 6 11.3 10.8 6 17.8 .05
Not discharged home 17.4 28.5 <.001
EVAR, Endovascular aneurysm repair; RBCs, red blood cells.
aCategoric data are shown as number (%) or percentage and continuous data as mean 6 standard deviation.
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Supplementary Table IV (online only). Procedural and postoperative details of patients undergoing open repair for
ruptured aneurysms
Variablea Men Women P
Total patients 276 (82) 62 (18)
Aneurysm diameter, mm 79.3 6 19.3 71.0 6 19.5 .005
Conversion from EVAR 2.9 3.2 >.99
Retroperitoneal exposure 5.8 6.5 .771
Distal anastomosis
Aorta 66.9 78.3 .231
Common iliac 18.1 11.7
External iliac 4.1 0.0
Common femoral 10.9 10.0
Proximal clamp position
Infrarenal 61.3 50.0 .096
Above one renal artery 8.9 5.0
Above both renal arteries 8.5 8.3
Supraceliac 21.4 36.7
Renal visceral ischemia time, minutes 12.3 6 27.2 16.5 6 25.2 .295
Estimated blood loss, mL 3996.5 6 3848.6 3335.5 6 3382.7 .220
Autotransfusion, mL 1597.8 6 1729.0 1012.1 6 1071.6 .013
Transfused packed RBCs, units
Intra-op 6.1 6 5.8 6.2 6 4.1 .962
Post-op 4.5 6 6.7 5.7 6 6.0 .330
Total procedural time, minutes 193.0 6 89.8 174.9 6 81.5 .158
Vasopressors required post-op 56.8 70.4 .069
Postoperative complications
Myocardial infarction 22.3 23.1 .857
Dysrhythmia 19.8 32.7 .045
Congestive heart failure 12.2 18.9 .190
Respiratory 52.4 56.6 .651
Change in renal function 32.7 32.7 >.99
Leg ischemia/emboli 6.8 15.1 .055
Bowel ischemia 17.4 24.1 .253
Wound complication 15.9 13.5 .834
Return to operating room 31.0 34.6 .633
Bleeding 32.7 35.3 >.99
Stroke 0.0 0.0 .
Length of stay, days
Intensive care unit 9.7 6 12.0 8.1 6 10.3 .356
Hospital 14.6 6 16.6 11.8 6 14.0 .209
Not discharged home 52.5 66.7 .169
EVAR, Endovascular aneurysm repair; RBCs, red blood cells.
aCategoric data are shown as number (%) or percentage and continuous data as mean 6 standard deviation.
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